What is the role of the European Medicines Agency (EMA)?

The European Medicines Agency (EMA) plays a crucial role in ensuring the safety and efficacy of medicinal products within the European Union. This agency is responsible for the scientific evaluation of medicines, providing expert assessments, and monitoring the safety of these products once they are on the market. The EMA reviews applications for new medicines and offers guidance throughout the development process, assisting companies in compliance with EU regulations.

The role of the EMA extends beyond just evaluating new drugs; it also involves the supervision of existing medicinal products to ensure they continue to meet safety standards. This oversight is vital for protecting public health and ensuring that all pharmaceutical products that enter the EU market are effective and safe for the consumer.

While the other options mention important aspects of pharmaceuticals, they do not accurately capture the EMA's primary function. The agency does not exclusively develop new drugs, set prices for pharmaceuticals, or monitor clinical trials globally, as its focus is specifically on evaluation and supervision within the EU framework.